This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
  • Home
  • /
  • Drugs
  • /
  • D
  • /
  • Doxazosin
  • /
  • Doxazosin DOXAZOSIN MESYLATE 1 mg/1 Zydus Lifesciences Limited
FDA Drug information

Doxazosin

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220825

Version

4

Spl Product Data Elements

Doxazosin Doxazosin DOXAZOSIN MESYLATE DOXAZOSIN CELLULOSE, MICROCRYSTALLINE LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO WHITE TO OFF-WHITE ROUND BICONVEX 783 Doxazosin Doxazosin DOXAZOSIN MESYLATE DOXAZOSIN CELLULOSE, MICROCRYSTALLINE FERRIC OXIDE RED LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO LIGHT PINK TO PINK ROUND BICONVEX 784 Doxazosin Doxazosin DOXAZOSIN MESYLATE DOXAZOSIN CELLULOSE, MICROCRYSTALLINE FERRIC OXIDE RED LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO LIGHT PINK TO PINK CAPSULE, BICONVEX 785 Doxazosin Doxazosin DOXAZOSIN MESYLATE DOXAZOSIN CELLULOSE, MICROCRYSTALLINE FD&C BLUE NO. 2 FD&C RED NO. 40 LACTOSE MONOHYDRATE MAGNESIUM STEARATE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO LIGHT PURPLE TO PURPLE ROUND BICONVEX 786

Application Number

ANDA208719

Brand Name

Doxazosin

Generic Name

Doxazosin

Product Ndc

70771-1112

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1112-1 in bottle of 100 Tablets Doxazosin Tablets USP, 1 mg Rx only 100 Tablets NDC 70771-1113-1 in bottle of 100 Tablets Doxazosin Tablets USP, 2 mg Rx only 100 Tablets NDC 70771-1114-1 in bottle of 100 Tablets Doxazosin Tablets USP, 4 mg Rx only 100 Tablets NDC 70771-1115-1 in bottle of 100 Tablets Doxazosin Tablets USP, 8 mg Rx only 100 Tablets container label 1 mg - 100s count container label 2 mg- 100s count container label 4 mg - 100s count container label - 8 mg - 100s count

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.